Last reviewed · How we verify
NCT05297019: HBOT
A Dosing Study of Hyperbaric Oxygen Therapy (HBOT) on Epigenetic Aging
Phase 2, PHASE3 trial testing Hyperbaric Oxygen Therapy in Aging in 30 participants. Status unknown.
30 April 2023
Quick facts
| Lead sponsor | TruDiagnostic |
|---|---|
| Phase | Phase 2, PHASE3 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | health services research |
| Enrollment | 30 |
| Start date | 1 March 2022 |
| Primary completion | 30 April 2023 |
| Estimated completion | 1 July 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Hyperbaric Oxygen Therapy — full drug profile →
Conditions studied
- Aging — all drugs for Aging →
Sponsor
TruDiagnostic — full company profile →
Who can join
Adults 40 to 70, any sex, with Aging. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to assess the impact of hyperbaric oxygen therapy on a number of outcomes, including epigenetic aging, inflammation, and cellular health.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05297019
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Hyperbaric Oxygen Therapy
Trials testing the same drug.
- NCT07473362 — Hyperbaric Oxygen Therapy for Post Traumatic Stress Disorder - a Pragmatic, Double Blinded Randomized Trial · NA · recruiting
- NCT07049692 — Hyperbaric Oxygen After Stroke Thrombectomy: A Multicenter Randomized Trial on Safety and Efficacy · NA · not yet recruiting
- NCT07514728 — Concept-verification Clinical Trial on the Inhibition of Breast Cancer Lung Metastasis Progression by Hyperbaric Oxygen · NA · enrolling by invitation
- NCT07170020 — Hyperbaric Oxygen Treatment for Necrotizing Fasciitis and Necrotizing Soft Tissue Infections · NA · not yet recruiting
- NCT07214415 — Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen Therapy · Phase 2 · recruiting
Other recruiting trials for Aging
Currently open trials in the same condition.
- NCT02831335 — Technical Development of Multi-Parametric Renocerebral MRI · recruiting
- NCT07099053 — Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging · recruiting
- NCT07504068 — Effects of Physical Exercise and a Nutritional Supplement on Body Composition, Metabolic Function, and Overall Health in · NA · recruiting
- NCT07525453 — Effects of Three Different Exercise Programs on Dynamic Balance in Community-Dwelling Older Adults · NA · recruiting
- NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting
Other TruDiagnostic trials
Trials by the same sponsor.
- NCT05535608 — Targeting the Nine Hallmarks of Aging on DNA Methylation · Phase 2 · unknown
- NCT05294835 — Ketamine and Epigenetic Aging · Phase 2 · unknown
- NCT05297097 — The Impact of a Human Breast Milk Supplement on Epigenetic and Cellular Markers · Phase 2 · unknown
- NCT04939155 — Methylation Effects of COV-19 Infection and Vaccinations · unknown
- NCT04946383 — Safety and Effectivness of Quercetin & Dasatinib on Epigenetic Aging · Phase 2 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05297019 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TruDiagnostic
- Last refreshed: 12 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05297019.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing